About CJC-1295 / Ipamorelin
This dual-peptide research vial combines CJC-1295 and Ipamorelin, two peptides studied in growth hormone-releasing and ghrelin-related signalling models. CJC-1295 is described in research as a long-acting GHRH analogue, while Ipamorelin is described as a selective growth hormone secretagogue pentapeptide. For product pages, describe this as a dual research peptide blend for laboratory studies involving GHRF and ghrelin-pathway signalling, not as a product for performance, body composition or hormone optimisation.
- High-purity CJC-1295 and Ipamorelin peptide blend
- Combined 5mg / 5mg vial
- Dual-peptide research format
- Third-party tested for quality and consistency
- Held in UK stock
- Research use only

Reviews
There are no reviews yet